Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects

Drug and Alcohol Dependence

Volumn 151, Issue , 2015, Pages 194-202

  Herrmann, Evan S ^a   Cone, Edward J ^a   Mitchell, John M ^b   Bigelow, George E ^a   LoDico, Charles ^c   Flegel, Ron ^c   Vandrey, Ryan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

Author keywords

Cannabis; Cognitive; Exposure; Marijuana; Secondhand; THC

Indexed keywords

CANNABINOID; CANNABIS; DRONABINOL; PSYCHEDELIC AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BREATH ANALYSIS; CANNABIS SMOKING; CONTROLLED STUDY; DIGIT SYMBOL SUBSTITUTION TEST; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY DISORDER; PASSIVE SMOKING; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; ROOM VENTILATION; SEDATION; SELF REPORT; TACHYCARDIA; URINALYSIS; URINE LEVEL; ADOLESCENT; AIR CONDITIONING; ATTENTION; BEHAVIOR; BLOOD; BLOOD PRESSURE; COGNITION; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; HEART RATE; MIDDLE AGED; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

CANNABIS; CANNABIS SATIVA;

ADOLESCENT; ADULT; ATTENTION; BEHAVIOR; BLOOD PRESSURE; CANNABIS; COGNITION; DRONABINOL; ENVIRONMENTAL EXPOSURE; FEMALE; HALLUCINOGENS; HEART RATE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; VENTILATION; YOUNG ADULT;

EID: 84930195094     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.03.019     Document Type: Article

References (32)

1. Casswell S., Marks D. Cannabis induced impairment of performance of a divided attention task. Nature 1973, 241:60-61.
2. Cone E.J., Bigelow G.E., Herrmann E.S., Mitchell J.M., LoDico C., Flegel R., Vandrey R. Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J. Anal. Toxicol. 2015, 39:1-12.
3. Cone E.J., Johnson R.E. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin. Pharmacol. Ther. 1986, 40:247-256.
4. Cone E.J., Johnson R.E., Darwin W.D., Yousefnejad D., Mell L.D., Paul B.D., Mitchell J. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. J. Anal. Toxicol. 1987, 11:89-96.
5. Cooper Z.D., Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 2014, 136:85-91.
6. Curran V.H., Brignell C., Fletcher S., Middleton P., Henry J. Cognitive and subjective dose-response effects of acute oral δ9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 2002, 164:61-70.
7. Fehr K.O.B., Kalant H. Analysis of cannabis smoke obtained under different combustion conditions. Can. J. Physiol. Pharmacol. 1972, 50:761-767.
8. Gronwall D.M. Paced auditory serial-addition task: a measure of recovery from concussion. Percept. Mot. Skills 1977, 44:367-373.
9. Gueorguieva R., Krystal J.H. Move over anova: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch. Gen. Psychiatry 2004, 61:310-317.
10. Hollister L.E., Gillespie H.K. Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis. Clin. Pharmacol. Ther. 1975, 18:714-719.
11. Hollister L.E., Gillespie H.K., Ohlsson A., Lindgren J.E., Wahlen A., Agurell S. Do plasma concentrations of δ9-tetrahydrocannabinol reflect the degree of intoxication?. J. Clin. Pharmacol. 1981, 21:171S-177S.
12. Hooker W.D., Jones R.T. Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology 1987, 91:20-24.
13. Hunault C.C., Böcker K.B., Stellato R.K., Kenemans J.L., de Vries I., Meulenbelt J. Acute subjective effects after smoking joints containing up to 69mg δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial. Psychopharmacology 2014, 231(24):4723-4733.
14. Huestis M.A., Henningfield J.E., Cone E.J. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J. Anal. Toxicol. 1992, 16:276-282.
15. Järbe T.U., Mechoulam R., Zahalka J. Discriminative stimulus-and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils. Pharmacol. Biochem. Behav. 1994, 47:113-119.
16. Kosersky D.S., McMillan D.E., Harris L.S. δ9-Tetrahydrocannabinol and 11-hydroxy-δ9-tetrahydrocannabinol: behavioral effects and tolerance development. J. Pharmacol. Exp. Ther. 1974, 189:61-65.
17. Law B., Mason P.A., Moffat A.C., King L.J., Marks V. Passive inhalation of cannabis smoke. J. Pharm. Pharmacol. 1984, 36:578-581.
18. Lemberger L., Martz R., Rodda B., Forney R., Rowe H. Comparative pharmacology of δ9-tetrahydrocannabinol and its metabolite, 11-OH-δ9-tetrahydrocannabinol. J. Clin. Invest. 1973, 52:2411-2417.
19. Mason A.P., Perez-Reyes M., McBay A.J., Foltz R.L. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke. J. Anal. Toxicol. 1983, 7:172-174.
20. 9 THC in the lung during smoking. Pharmacol. Biochem. Behav. 1997, 58:1145-1150.
21. McLeod D.R., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods 1982, 14:463-466.
22. Mehmedic Z., Chandra S., Slade D., Denham H., Foster S., Patel A.S., Ross S.A., Khan I.A., ElSohly M.A. Potency trends of (9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J. Forensic Sci. 2010, 55:1209-1217.
23. Milman G., Bergamaschi M.M., Lee D., Mendu D.R., Barnes A.J., Vandrey R., Huestis M.A. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence. Ther. Drug Monit. 2014, 36:218-224.
24. Moore C., Coulter C., Uges D., Tuyay J., Van der Linde S., Van Leeuwen A., Garnier M., Orbita J. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci. Int. 2011, 212:227-230.
25. Mørland J., Bugge A., Skuterud B., Steen A., Wethe G.H., Kjeldsen T. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. J. Forensic Sci. 1985, 30:997-1002.
26. Niedbala R.S., Kardos K.W., Fritch D.F., Kunsman K.P., Blum K.A., Newland G.A., Waga J., Kurtz L., Bronsgeest M., Cone E.J. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J. Anal. Toxicol. 2005, 29:607-615.
27. Perez-Reyes M., Davis K.H., Di Guiseppi S. Passive inhalation of marijuana smoke and urinary excretion of cannabinoids. JAMA 1983, 249:475.
28. Ramaekers J.G., Kauert G., Theunissen E.L., Toennes S.W., Moeller M.R. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J. Psychopharmacol. 2009, 23:266-277.
29. Ranganathan M., D'souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 2006, 188:425-444.
30. Vandrey R., Stitzer M.L., Mintzer M.Z., Huestis M.A., Murray J.A., Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013, 128:64-70.
31. Wilson W.H., Ellinwood E.H., Mathew R.J., Johnson K. Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res. 1994, 51:115-125.
32. World Health Organization Facts and Figures, Cannabis 2014, World Health Organization, http://www.who.int/substance:abuse/facts/cannabis/en/